Minnesota Administrative Rules
Agency 144 - Health Department
Chapter 4770 - MEDICAL CANNABIS
Part 4770.1850 - RECALL PROCEDURES
Current through Register Vol. 49, No. 13, September 23, 2024
A. Each manufacturer must establish a procedure for recalling medical cannabis that has a reasonable probability of causing an unexpected or harmful response in a patient population, despite appropriate use, that outweighs the potential benefit of the medication. This procedure must include:
B. The commissioner may order a manufacturer to undertake a recall of a dried raw cannabis finished good. The commissioner's order must be based on a reasonable suspicion that the finished good presents a risk of causing a serious adverse incident. The commissioner must order the recall of a dried raw cannabis finished good if testing under part 4770.3035 indicates the presence of residues from a crop input prohibited under part 4770.1700 are present in the finished good. A manufacturer must comply and cooperate with any recalls ordered by the commissioner.